HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Onyx plans phase III trial of ONYX-015 for head & neck cancer.

Authors
JournalThe oncologist (Oncologist) Vol. 4 Issue 5 Pg. 432 ( 1999) ISSN: 1083-7159 [Print] England
PMID10551563 (Publication Type: News)
Topics
  • Adenoviridae (genetics)
  • Clinical Trials, Phase III as Topic
  • Genetic Therapy
  • Head and Neck Neoplasms (drug therapy)
  • Humans
  • United States
  • United States Food and Drug Administration

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: